Business Context and Reporting Period
Company: Bruker Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: June 9, 2009
Event: Regulation FD Disclosure regarding a presentation at the Goldman Sachs 30th Annual Global Healthcare Conference in New York, NY.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of a presentation containing previously non-public information.
Material Changes
No material financial changes are detailed in the text of this filing. The document references slides 5 through 7 of the attached presentation (Exhibit 99.1) as containing the non-public information, but the content of those slides is not included in the provided text.
Guidance, Outlook, and Risks
Management Commentary: The Company presented materials at an investor conference. The presentation is available on the Company's investor relations website.
Legal Status: The information furnished in this report and its exhibits is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that Section. It shall not be deemed incorporated by reference into any other filing unless specifically identified as such.
Investor Verification Checklist
- Verify the content of slides 5 through 7 in the June 9, 2009 PowerPoint presentation (Exhibit 99.1) available on the Bruker investor relations website.
- Confirm whether the non-public information disclosed in the presentation impacts current financial guidance or operational outlook.
- Review subsequent filings to determine if the information presented has been formally incorporated by reference.